NervGen Pharma Corp. (NGENF)

NervGen Pharma Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	15.67	17.27	11.66	22.45	16.93	5.6
Cash & Short-Term Investments	15.67	17.27	11.66	22.45	16.93	5.6
Cash Growth	-40.98%	48.10%	-48.07%	32.62%	202.38%	36.34%
Accounts Receivable	0.06	0.1	-	-	-	-
Other Receivables	0.1	0.42	0.25	0.03	0.06	0.06
Receivables	0.15	0.51	0.25	0.03	0.06	0.06
Prepaid Expenses	0.13	0.18	0.11	0.08	0.07	0.05
Other Current Assets	0.53	1.05	0.5	0.59	0.36	0.49
Total Current Assets	16.49	19.01	12.52	23.15	17.42	6.2
Property, Plant & Equipment	-	-	0.2	0.3	0	0
Other Intangible Assets	0.44	0.46	0.52	0.43	0.47	0.47
Long-Term Accounts Receivable	-	0.01	-	-	-	-
Total Assets	16.92	19.49	13.24	23.88	17.9	6.68
Accounts Payable	0.04	-	3.32	2	0.35	0.17
Accrued Expenses	5.18	4.94	-	1.4	0.73	0.58
Current Portion of Leases	0.06	0.1	0.09	0.09	-	-
Other Current Liabilities	12.56	11.86	11.73	6.73	-	-
Total Current Liabilities	17.84	16.9	15.14	10.22	1.08	0.76
Long-Term Leases	-	0.01	0.11	0.2	-	-
Total Liabilities	17.84	16.91	15.25	10.41	1.08	0.76
Common Stock	88.42	81.1	58.93	57.41	42.4	22.95
Retained Earnings	-115.21	-102.16	-78.15	-55.77	-35.05	-22.32
Comprehensive Income & Other	25.87	23.64	17.21	11.82	9.46	5.3
Shareholders' Equity	-0.92	2.58	-2.01	13.46	16.82	5.92
Total Liabilities & Equity	16.92	19.49	13.24	23.88	17.9	6.68
Total Debt	0.06	0.11	0.2	0.28	-	-
Net Cash (Debt)	15.62	17.16	11.46	22.17	16.93	5.6
Net Cash Growth	-40.86%	49.72%	-48.29%	30.95%	202.38%	36.34%
Net Cash Per Share	0.22	0.25	0.19	0.42	0.43	0.17
Filing Date Shares Outstanding	73.28	70.99	69.93	59.13	46.23	35.86
Total Common Shares Outstanding	72.84	70.33	59.61	58.78	46.19	35.17
Working Capital	-1.36	2.11	-2.62	12.93	16.34	5.45
Book Value Per Share	-0.01	0.04	-0.03	0.23	0.36	0.17
Tangible Book Value	-1.36	2.11	-2.53	13.03	16.35	5.45
Tangible Book Value Per Share	-0.02	0.03	-0.04	0.22	0.35	0.15

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.